Content about Generics

March 14, 2011
'60 Minutes' examines counterfeit drug problem

"Fake drugs are a big threat and an exploding threat," Kumar Kibble, deputy director of Immigration and Customs Enforcement, told the news program "60 Minutes" in a segment that appeared Sunday night.

March 14, 2011
PTCB's CREST Summit emphasized pharmacy's role in health care

By 2015, “pharmacists will be the healthcare professionals responsible for providing patient care that ensures optimal medication therapy outcomes.” That was the consensus reached in the Joint Commission of Pharmacy Practitioners' vision statement at the Pharmacy Technician Certification Board’s Consumer Awareness, Resources, Education, State Policy and Testing Summit last month.

March 10, 2011
Hospira gets OK to market generic Taxotere

Hospira has received approval from the Food and Drug Administration for a generic cancer treatment.

March 10, 2011
Under PEPFAR, Matrix Labs gets OK to sell zidovudine tablets

A subsidiary of Mylan has won approval to sell a generic drug for HIV and AIDS in developing countries under the President’s Emergency Plan for AIDS Relief.

March 9, 2011
Watson promotes two SVPs

Generic drug maker Watson Pharmaceuticals has promoted two executives to EVP, the company said Wednesday.

March 8, 2011
Allergan executive moves to CEO role at Hospira

Generic drug maker Hospira has appointed Mike Ball as CEO, effective March 28, the company said. Ball currently is president of Allergan.

March 4, 2011
Endo elects new board member

Endo's board of directors has expanded to nine members with the addition of David Nash.

March 4, 2011
FDA: Topiramate could pose birth defects risk

Pregnant mothers taking a common drug for treating epilepsy may be putting their babies at risk, according to a new report from the Food and Drug Administration.

March 4, 2011
Hospira launches catalog of U.S. products on website

Hospira launched a new online resource that catalogs all of its products available in the United States.

March 4, 2011
Oral contraceptive Emoquette wins FDA approval

A subsidiary of Endo Pharmaceuticals has won approval from the Food and Drug Administration for an oral contraceptive.

March 4, 2011
ReportersNotebook — Chain Pharmacy, 3/14/11

SUPPLIER NEWS — Impax Labs received regulatory approval from the Food and Drug Administration for its generic version of a bacterial infection treatment. The drug maker said the FDA approved its 150-mg doxycycline monohydrate capsules, a drug used to treat bacterial infections and a generic version of Adoxa, made by Nycomed subsidiary PharmaDerm. The 150-mg strength of Adoxa had sales of about $25 million during the 12 months ended in December 2010, according to Wolters Kluwer.

March 3, 2011
Amneal receives FDA approval for generic Indocin

The Food and Drug Administration has approved a generic drug for pain and inflammatory diseases made by Amneal Pharmaceuticals, Amneal said Thursday.

March 3, 2011
NACDS responds to reimportation legislation

In a letter penned Thursday by the National Association of Chain Drug Stores to Sen. Olympia Snowe, R-Maine, the association stated that while it shares the goal of reducing prescription drug costs, authorizing the reimportation of prescription medications — as sought in S.319, the Pharmaceutical Market Access and Drug Safety Act of 2011 — raises concerns about patient health and safety.

March 3, 2011
NSAIDs could pose erectile dysfunction risk among men

Long-term use of a class of drugs used to control pain could increase the risk of erectile dysfunction in men, according to a new study.

March 3, 2011
PCMA leader honored by GPhA

The head of a group representing the nation's pharmacy benefit managers got honors from the Generic Pharmaceutical Association.

March 2, 2011
Drug makers file suit against Mylan over generic Vivelle-Dot

A group of drug makers have sued Mylan over its attempt to gain Food and Drug Administration approval for a generic menopause drug, Mylan said Tuesday.

March 2, 2011
FDA targets unapproved cough-cold, allergy drugs with Unapproved Drugs Initiative

The Food and Drug Administration has taken action against makers of prescription drugs for cough-cold and allergies that don’t have regulatory approval, the agency said Wednesday.

March 1, 2011
Express Scripts finds generic antidepressant users as adherent as brand-name counterparts

Patients who take generic antidepressants will remain as adherent as those who take brand-name drugs to treat the condition, according to a new study.

March 1, 2011
Heather Bresch, Robert Cindrich join Mylan's board

Mylan's board of directors now includes the drug maker's president.

March 1, 2011
Trial date set for generic Copaxone litigation

Teva on Tuesday said that a trial date has been set for its ongoing patent infringement litigation against several drug makers.

February 28, 2011
Matrix Labs' gabapentin capsules get FDA OK

The Food and Drug Administration has approved a treatment for shingles made by a subsidiary of generic drug maker Mylan.

February 25, 2011
Watson seeks regulatory approval for generic Adderall XR

Watson Labs is hoping to be the first to market a generic version of a popular drug for attention deficit hyperactivity disorder.

February 24, 2011
Par sees sales gains across all sectors

Generic drug maker Par Pharmaceutical Cos. had sales of $227 million during fourth quarter 2010 and $1 billion for the year as a whole, according to an earnings statement Thursday.

February 23, 2011
Caraco, Sun to merge

Generic drug maker Caraco Pharmaceutical Industries will merge with Sun Pharmaceutical Industries, Caraco said Tuesday.

February 22, 2011
GPhA announces executive committee, board of directors

The Generic Pharmaceutical Association has elected its 2011 executive committee and board of directors, the generic drug industry trade group announced. As part of a reorganization last year, the board has been reduced to 12 members.

© 2013 Drug Store News. All Rights Reserved.